osaühing TBD Pharmatech
Registry code: 11204964
ActiveEstoniaFinancial Reports
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue | 4 841 495 | 5 168 441 | 4 115 740 | 6 286 179 | |
| Profit Before Tax | 1 283 899 | 232 329 | −212 477 | 1 435 811 | |
| Net Profit | 1 292 402 | 234 758 | −179 441 | 1 450 675 | |
| Profit margin | 26.7% | 4.5% | -4.4% | 23.1% | |
| Equity | 4 823 739 | 5 058 497 | 4 879 620 | 6 330 295 | |
| Liabilities | 527 799 | 907 270 | 647 501 | 5 401 262 | |
| Total Assets | 5 351 538 | 5 965 767 | 5 527 121 | 11 731 557 |
Financial Reports
2024(—)
Balance Sheet
Total Assets11 731 557 €
Long-term Assets6 917 789 €
Short-term Assets4 813 768 €
Equity6 330 295 €
Liabilities5 401 262 €
Profit & Loss Statement
Revenue6 286 179 €
Profit Before Tax1 435 811 €
Net Profit1 450 675 €
2023(—)
Balance Sheet
Total Assets5 527 121 €
Long-term Assets1 657 623 €
Short-term Assets3 869 498 €
Equity4 879 620 €
Liabilities647 501 €
Profit & Loss Statement
Revenue4 115 740 €
Profit Before Tax−212 477 €
Net Profit−179 441 €
2022(—)
Balance Sheet
Total Assets5 965 767 €
Long-term Assets1 529 432 €
Short-term Assets4 436 335 €
Equity5 058 497 €
Liabilities907 270 €
Profit & Loss Statement
Revenue5 168 441 €
Profit Before Tax232 329 €
Net Profit234 758 €
2021(—)
Balance Sheet
Total Assets5 351 538 €
Long-term Assets1 963 862 €
Short-term Assets3 387 676 €
Equity4 823 739 €
Liabilities527 799 €
Profit & Loss Statement
Revenue4 841 495 €
Profit Before Tax1 283 899 €
Net Profit1 292 402 €
2020(—)
Balance Sheet
Total Assets3 895 176 €
Long-term Assets1 234 477 €
Short-term Assets2 660 699 €
Equity3 531 337 €
Liabilities363 839 €
Profit & Loss Statement
Revenue4 568 917 €
Profit Before Tax1 458 591 €
Net Profit1 469 997 €
2019(—)
Balance Sheet
Total Assets2 437 126 €
Long-term Assets919 322 €
Short-term Assets1 517 804 €
Equity2 061 340 €
Liabilities375 786 €
Profit & Loss Statement
Revenue3 255 697 €
Profit Before Tax946 592 €
Net Profit946 069 €
Source: Äriregister